Sensei Biotherapeutics Is A Clinical Stage Biotechnology Company Based In Rockvillemarylandthe Company Focuses On Discovering And Developing Next Generation Therapeutics For Cancerparticularly In Immuno Oncologysensei Biotherapeutics Aims To Utilize The Immune System To Combat Cancer By Creating Conditionally Active Antibodies That Work Selectively Within The Tumor Microenvironment The Company Employs Its Tmabtumor Microenvironment Activated Biologicsplatform To Develop Therapeutics That Either Disable Immunosuppressive Signals Or Activate Immunostimulatory Signals In Tumorsits Product Pipeline Includes Several Candidates For Treating Solid Tumorssuch As Sns 101Sns 201Sns 102And Sns 103A Key Product Candidate Is Solnerstotugwhich Targets The Vista Checkpoint In The Tumor Microenvironment Sensei Biotherapeutics Collaborates With Notable Partners In The Biotechnology And Pharmaceutical Industriesincluding Regeneron Pharmaceuticals And The National Cancer Instituteto Advance Cancer Treatmentsthe Company Is Committed To Leveraging Innovative Technologies To Develop Targeted Therapies For Cancer Patients
